Biomedical engineer advances sustainable wound care by converting chicken feather waste into biocompatible hydrogel ...

Consideration for portfolio will consist of a $15 million upfront cash payment and potentially an additional $20 million in milestone payments ...

Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately ...

NEXGEL, Inc. (NASDAQ:NXGL) has signed an asset purchase and exclusive licensing agreement with Celularity, Inc. to obtain rights to Celularity’s commercial-stage regenerative biomaterials portfolio, ...

Tissue engineering and regenerative medicine require biomaterials that support cellular proliferation, migration, and self-organization to develop functional tissue structures. Granular hydrogel ...

NexGel Inc. NXGL on Tuesday agreed to license and acquire a portfolio of commercial-stage regenerative biomaterial products from Celularity, Inc. CELU, a regenerative and cellular medicine company.

Hydrogels with particulates, including proteins, drugs, nanoparticles, and cells, enable the development of new and innovative biomaterials. Precise control of the spatial distribution of these ...

A cube of healthy bone is anything but solid. Inside it, countless tiny channels carry fluid and help cells move, feed, and ...

Two innovative UCSF projects in hydrogel therapies to develop new salivary glands and restore muscle loss after facial injuries have received critical funding to move closer to clinical trials. If the ...

Researchers are one step closer to bioprinting organs and tissues using a novel granular hydrogel bioink. Every 9 minutes a person is added to the organ transplant waiting list in the United States, ...

Zustiak’s primary research interests are in hydrogel biomaterials and tissue engineering, with emphasis on developing novel biomaterials as cell scaffolds and drug screening platforms, and elucidating ...